Study examines outcomes of use of beta-blockers around time of surgery for higher-risk patients

April 23, 2013

Patients at elevated cardiac risk who were treated with beta-blockers on the day of or following noncardiac, nonvascular surgery had significantly lower rates of 30-day mortality and cardiac illness, according to a study in the April 24 issue of JAMA.

"The effectiveness and safety of perioperative beta-blockade [the process of inhibiting beta-] for patients undergoing noncardiac remains controversial. Class I recommendations in the current /American College of Cardiology Foundation Guidelines on Perioperative Evaluation and Care for Noncardiac Surgery remain limited to continuation of preexisting beta-blockade," according to background information in the article. "Recent evidence suggests that use of perioperative beta-blockade may be declining. Contributing factors may include uncertainty about safety and recent data questioning the efficacy of long-term beta-blockade in stable outpatients. Thus, additional multicenter analyses of associations of perioperative beta-blockade with outcome are timely and potentially relevant to clinicians and regulatory agencies promoting perioperative quality and safety efforts."

Martin J. London. M.D., of the U.S. Department of Veterans Affairs Medical Center and University of California, San Francisco, and colleagues conducted a study to examine the association of perioperative beta-blockade with all-cause 30-day mortality and (cardiac arrest or Q-wave [a reading on an ] ) in patients undergoing major noncardiac surgery. The analysis included a population-based sample of 136,745 patients who were 1:1 matched on propensity scores (37,805 matched pairs) treated at 104 VA medical centers from January 2005 through August 2010.

Overall, 45,347 patients (33.2 percent) had an active outpatient prescription for beta-blockers within 7 days of surgery and 55,138 patients (40.3 percent) were potentially exposed to beta-blockers on either postoperative day 0 or 1. Inpatient beta-blocker exposure was higher in the 66.7 percent of 13,863 patients who underwent vascular surgery than in the 37.4 percent of 122,882 patients who underwent nonvascular surgery. The rate of use increased with increasing Revised Index variables: 25.3 percent for no factors vs. 71.3 percent for 4 or more factors.

Overall, 1,568 patients (1.1 percent) sustained the primary 30-day mortality outcome and 1,196 patients (0.9 percent) the secondary cardiac morbidity outcome. The researchers found that in the matched cohort, patients in the exposed group had a 27 percent lower risk of mortality. Significant associations of beta-blocker exposure with lower mortality were noted in patients with 2 Revised Cardiac Risk Index factors (37 percent lower mortality risk), 3 factors (46 percent lower risk), or 4 factors or more (60 percent lower risk). This association was limited to patients undergoing nonvascular surgery.

Considering the secondary cardiac morbidity outcome, beta-blocker exposure was associated with a 33 percent lower risk of cardiac complications, also limited to patients undergoing nonvascular surgery.

"In conclusion, our results suggest that early perioperative beta-blocker exposure is associated with significantly lower rates of 30-day mortality and cardiac morbidity in patients at elevated baseline cardiac risk undergoing nonvascular surgery. Although assessment of cumulative number of Revised Cardiac predictors might be helpful to clinicians in deciding whether to use perioperative beta-blockade, the current findings highlight a need for a randomized multi-center trial of perioperative beta-blockade in low- to intermediate-risk scheduled for noncardiac surgery," the authors write.

Explore further: Pre-surgery beta blockers, risk of death examined in noncardiac surgery

More information: JAMA. 2013;309(16):1704-1713

Related Stories

Pre-surgery beta blockers, risk of death examined in noncardiac surgery

May 27, 2015
The controversial practice of administering pre-surgery beta-blockers to patients having noncardiac surgery was associated with an increased risk of death in patients with no cardiac risk factors but it was beneficial for ...

Beta-blockers before surgery appear associated with lower risk of heart-related events

November 18, 2013
Giving beta-blocker medication to patients with heart disease undergoing noncardiac surgery appears to be associated with a lower risk of death and major adverse cardiovascular events (MACE) 30 days after surgery in patients ...

Beta blockers and perioperative care: EHJ addresses controversy

February 7, 2014
Since the end of 2011 when the scientific work of Professor Don Poldermans was first scrutinized there has been controversy in the medical world about the use of beta blockers in perioperative care.

Experiencing a-fib while hospitalized for surgery linked with increased risk of stroke

August 12, 2014
In a study that included 1.7 million patients undergoing inpatient surgery, experiencing atrial fibrillation while hospitalized was associated with an increased long-term risk of ischemic stroke, especially following noncardiac ...

Beta-blockers may increase adverse cardiac events, patients at risk during noncardiac surgical procedure

October 28, 2013
A recent study shows that patients given beta-blockers may actually be at increased risk of having an adverse cardiac event during a noncardiac surgical procedure. Risk of irregular heartbeat and worsening of symptoms in ...

Recommended for you

Laser device placed on the heart identifies insufficient oxygenation better than other measures

September 20, 2017
A new device can assess in real time whether the body's tissues are receiving enough oxygen and, placed on the heart, can predict cardiac arrest in critically ill heart patients, report researchers at Boston Children's Hospital ...

Metabolism switch signals end for healing hearts

September 19, 2017
Researchers have identified the process that shuts down the human heart's ability to heal itself, and are now searching for a drug to reverse it.

Beta blockers not needed after heart attack if other medications taken

September 18, 2017
A new study from the University of North Carolina at Chapel Hill finds beta blockers are not needed after a heart attack if heart-attack survivors are taking ACE inhibitors and statins. The study is the first to challenge ...

Which single behavior best prevents high blood pressure?

September 15, 2017
(HealthDay)—You probably already know that certain healthy lifestyle behaviors can reduce your risk of developing high blood pressure, but is any one behavior more important than the others?

RESPECT trial shows closing a small hole in heart may protect against recurrent stroke

September 13, 2017
A device used to close a small hole in the heart may benefit certain stroke patients by providing an extra layer of protection for those facing years of ongoing stroke risk, according to the results of a large clinical trial ...

Study shows so-called 'healthy obesity' is harmful to cardiovascular health

September 11, 2017
Clinicians are being warned not to ignore the increased cardiovascular health risks of those who are classed as either 'healthy obese' or deemed to be 'normal weight' but have metabolic abnormalities such as diabetes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.